IRM des cardiomyopathies restrictives

  • P. Germain
  • S. El Ghannudi-Abdo
  • U. Crimizade
  • M. Y. Jeung
Conference paper

Résumé

Les cardiomyopathies restrictives (CMR) concernent un ensemble de pathologies hétérogènes dont le dénominateur commun est constitué par les anomalies de remplissage de type restrictif. L’IRM occupe dans ce domaine une place importante en facilitant grandement le diagnostic différentiel avec les péricardites constrictives (ce qui est essentiel pour le choix thérapeutique) et grâce à la séméiologie relativement spécifique qu’elle apporte pour l’identification de l’amylose, de la maladie de Fabry et de la fibrose endomyocardique.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Richardson P, McKenna W, Bristow M et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841–842PubMedCrossRefGoogle Scholar
  2. 2.
    Elliott P, Andersson B, Arbustini E et al. (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29: 270–276PubMedCrossRefGoogle Scholar
  3. 3.
    Langlard JM (2010) Cardiomyopathies restrictives. EMC (Elsevier Masson SAS, Paris), Cardiologie, 11-023-A-10Google Scholar
  4. 4.
    Abergel E (2003) Remplissage et diastole ventriculaire gauche in Echocardiographie clinique de l’adulte. Paris, Estem: 257–89Google Scholar
  5. 5.
    Francone M, Dymarkowski S, Kalantzi M, Rademakers FE, Bogaert J (2006) Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 16: 944–951PubMedCrossRefGoogle Scholar
  6. 6.
    Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G (1998) Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 136: 824–830PubMedCrossRefGoogle Scholar
  7. 7.
    Hansen MW, Merchant N (2007) MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol 189: 1344–1352PubMedCrossRefGoogle Scholar
  8. 8.
    Van Geluwe F, Dymarkowski S, Crevits I, De Wever W, Bogaert J (2006) Amyloidosis of the heart and respiratory system. Eur Radiol 16: 2358–2365PubMedCrossRefGoogle Scholar
  9. 9.
    Vogelsberg H, Mahrholdt H, Deluigi CC et al. (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51: 1022–1030PubMedCrossRefGoogle Scholar
  10. 10.
    Ruberg FL, Appelbaum E, Davidoff R et al. (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103: 544–549PubMedCrossRefGoogle Scholar
  11. 11.
    Perugini E, Rapezzi C, Piva T et al. (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92: 343–349PubMedCrossRefGoogle Scholar
  12. 12.
    Maceira AM, Joshi J, Prasad SK et al. (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111: 186–193PubMedCrossRefGoogle Scholar
  13. 13.
    Lyne JC, Petryka J, Pennell DJ (2008) Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis. Eur Heart J 29: 212PubMedCrossRefGoogle Scholar
  14. 14.
    Rohan I, vanden Driesen, Richard E (2006) Slaughter and Wendy E. Strugnell. MR Findings in Cardiac Amyloidosis. AJR 186: 1682–1685CrossRefGoogle Scholar
  15. 15.
    Migrino RQ, Christenson R, Szabo A, Bright M, Truran S, Hari P (2009) Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up. BMC Med Phys 9: 5PubMedCrossRefGoogle Scholar
  16. 16.
    Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10: 54PubMedCrossRefGoogle Scholar
  17. 17.
    Krombach GA, Hahn C, Tomars M et al. (2007) Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 25: 1283–1287PubMedCrossRefGoogle Scholar
  18. 18.
    Hosch W, Bock M, Libicher M et al. (2007) MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Invest Radiol 42: 636–642PubMedCrossRefGoogle Scholar
  19. 19.
    Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184: 249–254PubMedCrossRefGoogle Scholar
  20. 20.
    Smedema JP, Snoep G, van Kroonenburgh MP et al. (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45: 1683–1690PubMedCrossRefGoogle Scholar
  21. 21.
    Dorfman T, Canales J, Farukhi I, McGuire DK (2005) Sarcoidosis masquerading as an acute coronary syndrome. Cardiol Rev 13: 256–259PubMedCrossRefGoogle Scholar
  22. 22.
    Tadamura E, Yamamuro M, Kubo S et al. (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185: 110–115PubMedCrossRefGoogle Scholar
  23. 23.
    Smedema JP, Snoep G, van Kroonenburgh MP et al. (2005) The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128: 1629–1637PubMedCrossRefGoogle Scholar
  24. 24.
    Carpenter JP, Pennell DJ (2008) Cardiovascular magnetic resonance and thalassaemia. Int J Cardiovasc Imaging 24: 857–859PubMedCrossRefGoogle Scholar
  25. 25.
    Moon JC, Sachdev B, Elkington AG et al. (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24: 2151–2155PubMedCrossRefGoogle Scholar
  26. 26.
    Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8: 479–482PubMedCrossRefGoogle Scholar
  27. 27.
    Chao BH, Cline-Parhamovich K, Grizzard JD, Smith TJ (2007) Fatal Loeffler’s endocarditis due to hypereosinophilic syndrome. Am J Hematol 82: 920–923PubMedCrossRefGoogle Scholar
  28. 28.
    Bukhman G, Ziegler J, Parry E (2008) Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis 2: e97PubMedCrossRefGoogle Scholar
  29. 29.
    Salanitri GC (2005) Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. AJR Am J Roentgenol 184: 1432–1433PubMedCrossRefGoogle Scholar
  30. 30.
    Seth S, Thatai D, Sharma S, Chopra P, Talwar KK (2004) Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India. Eur J Heart Fail 6: 723–729PubMedCrossRefGoogle Scholar
  31. 31.
    Syed IS, Martinez MW, Feng DL, Glockner JF (2008) Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol 126: e50–e52PubMedCrossRefGoogle Scholar
  32. 32.
    Hunold P, Schlosser T, Vogt FM et al. (2005) Myocardial late enhancement in contrastenhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 184: 1420–1426PubMedCrossRefGoogle Scholar
  33. 33.
    Smedema JP, Winckels SK, Snoep G, Vainer J, Bekkers SC, Crijns HJ (2004) Tropical endomyocardial fibrosis (Davies’ disease): case report demonstrating the role of magnetic resonance imaging. Int J Cardiovasc Imaging 20: 517–522PubMedCrossRefGoogle Scholar
  34. 34.
    Cury RC, Abbara S, Sandoval LJ, Houser S, Brady TJ, Palacios IF (2005) Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging. Circulation 111: e115–e117PubMedCrossRefGoogle Scholar
  35. 35.
    Senra T, Shiozaki AA, Salemi VM, Rochitte CE (2008) Delayed enhancement by multidetector computed tomography in endomyocardial fibrosis. Eur Heart J 29: 347PubMedCrossRefGoogle Scholar
  36. 36.
    Des références et une iconographie plus complètes, comportant également des boucles vidéo de ciné cardiaque sont disponibles sur le site www.irmcardiaque.com.Google Scholar

Copyright information

© Springer-Verlag France, Paris 2011

Authors and Affiliations

  • P. Germain
    • 1
  • S. El Ghannudi-Abdo
    • 2
  • U. Crimizade
    • 2
  • M. Y. Jeung
    • 1
  1. 1.Service de radiologieHôpitaux universitaires de StrasbourgStrasbourg Cedex
  2. 2.Service de cardiologieHôpitaux universitaires de StrasbourgStrasbourg Cedex

Personalised recommendations